Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1992 Publications

  1. Capps, D.B., J. Dunbar, S.R. Kesten, J. Shillis, L.M. Werbel, J. Plowman and D.L. Ward, 1992. 2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-k]acridines, a New Class of Anticancer Agents, J. Med. Chem., 35, 4770-4778.
  2. Hendriks, H.R., J. Plowman, D.P. Berger, K.D. Paull, H.H. Fiebig, Ø. Fodstat, H.C. Dreef-van der Meulen, R.E.C. Henrar, H.M. Pinedo and G. Schwartsmann, 1992. Preclinical Antitumor Activity and Animal Toxicology Studies of Rhizoxin, a Novel Tubulin-interacting Agent, Annals of Oncol., 3, 755-763.
  3. Hollingshead, M.G., L. Westbrook, M.J. Ross, J. Bailey, K.J. Qualls and L.B. Allen, 1992. An ELISA System for Evaluating Antiretroviral Activity Against Rauscher Murine Leukemia Virus, Antiviral Res., 18, 267-274.
  4. Supko, J.G. and L. Malspeis, 1992. Liquid Chromatographic Analysis of 9-aminocamptothecin in Plasma Monitored by Fluorescence Induced upon Post-column Acidification, J Liquid Chromatogr., 15, 3261-3283.
  5. Waud, W.R., K.S. Gilbert, S.D. Harrison, Jr and D.P. Griswold, Jr, 1992. Cross-resistance of Drug-resistant Murine P388 Leukemias to Taxol (NSC 125973), Cancer Chemother. Pharmacol., 31, 255-257.
  6. Waud, W.R., J. Plowman, S.D. Harrison, Jr, D.J. Dykes, W.K. Anderson and D.P. Griswold, Jr, 1992. Antitumor Activity and Cross-resistance of Carmethizole Hydrochloride (NSC 602668) in Preclinical Models in Mice, Cancer Chemother. Pharmacol., 30, 261-266.
  7. Zaharko, D.S., J. Plowman, W. Waud, D. Dykes and L. Malspeis, 1992. L-Histidinol: Preclinical Therapeutic Studies in Combination with Antitumor Agents and Pharmacokinetic Studies in Mice, Cancer Res., 52, 3604-3609.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director,